Literature DB >> 11108824

5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test.

J F Cryan1, I Lucki.   

Abstract

The receptors responsible for mediating the antidepressant effects of selective serotonin reuptake inhibitors are largely unknown. The role of the 5-HT4 receptor in mediating the antidepressant-like effects of fluoxetine in a modified rat forced swim test was examined. Fluoxetine (20 mg/kg) decreased immobility and increased swimming, a pattern shown to represent its actions on the serotonergic system. The selective 5-HT4 receptor antagonist, SB 204070A [8-amino-7-chloro-(N-butyl-4-piperidyl)methylbenzo-1, 4-dioxan-5-carboxylate hydrochloride] (0.1-3 mg/kg), failed to change any of the active behaviors in the test compared with saline-treated animals. Upon combination, SB 204070A (3 mg/kg) failed to alter the effects of fluoxetine effects in the test. These data therefore suggest that activation of postsynaptic 5-HT4 receptors, subsequent to reuptake inhibition by fluoxetine, is not necessary for its antidepressant-like behavioral effects in this test.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108824     DOI: 10.1016/s0014-2999(00)00858-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  5-HT(2B) receptors are required for serotonin-selective antidepressant actions.

Authors:  S L Diaz; S Doly; N Narboux-Nême; S Fernández; P Mazot; S M Banas; K Boutourlinsky; I Moutkine; A Belmer; A Roumier; L Maroteaux
Journal:  Mol Psychiatry       Date:  2011-12-13       Impact factor: 15.992

2.  Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine.

Authors:  Pauline Belujon; Nicole L Jakobowski; Hannah K Dollish; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2015-07-01       Impact factor: 7.853

Review 3.  The role of serotonin receptor subtypes in treating depression: a review of animal studies.

Authors:  Gregory V Carr; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-11-24       Impact factor: 4.530

Review 4.  Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.

Authors:  Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David
Journal:  Neuroscientist       Date:  2014-12-08       Impact factor: 7.519

5.  Sex-specific programming of offspring emotionality after stress early in pregnancy.

Authors:  Bridget R Mueller; Tracy L Bale
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

6.  Acute illness-induced behavioral alterations are similar to those observed during withdrawal from acute alcohol exposure.

Authors:  Laura Richey; Tamara L Doremus-Fitzwater; Hollin M Buck; Terrence Deak
Journal:  Pharmacol Biochem Behav       Date:  2012-08-17       Impact factor: 3.533

7.  Possible involvement of the JAK/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects.

Authors:  Marwa M Al-Samhari; Nouf M Al-Rasheed; Salim Al-Rejaie; Nawal M Al-Rasheed; Iman H Hasan; Ayman M Mahmoud; Nduna Dzimiri
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-06

Review 8.  Mechanisms of antidepressant resistance.

Authors:  Wissam El-Hage; Samuel Leman; Vincent Camus; Catherine Belzung
Journal:  Front Pharmacol       Date:  2013-11-22       Impact factor: 5.810

Review 9.  The role of 5-HT receptors in depression.

Authors:  Christine N Yohn; Mark M Gergues; Benjamin Adam Samuels
Journal:  Mol Brain       Date:  2017-06-24       Impact factor: 4.041

Review 10.  Translating the promise of 5HT4 receptor agonists for the treatment of depression.

Authors:  Susannah E Murphy; Angharad N de Cates; Amy L Gillespie; Beata R Godlewska; Jessica C Scaife; Lucy C Wright; Philip J Cowen; Catherine J Harmer
Journal:  Psychol Med       Date:  2020-04-03       Impact factor: 7.723

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.